Retinal Anastomosis to Choroidal Neovascularization

Long-Term Management of RAP Lesions in Clinical Practice: Treatment Efficacy and Predictors of Functional Improvement

“…RAP is believed to have a worse natural history than other subtypes of exudative AMD [23]. Over the past years, the success rate of the various available treatments has been inconsistent.…”

Long-Term Management of RAP Lesions in Clinical Practice: Treatment Efficacy and Predictors of Functional Improvement

“…RAP is believed to have a worse natural history than other subtypes of exudative AMD [23]. Over the past years, the success rate of the various available treatments has been inconsistent.…”

Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation

“…RAP is known to have poor visual outcomes compared with typical exudative AMD [4,5,9,13]. In addition, the risk of neovascularization in the fellow eye is higher for patients with RAP than for those with other forms of neovascular AMD [6].…”

“…At month 24, OCT revealed the recurrence of CME in three eyes, the recurrence of PED in one eye, and remaining PED in one eye (Table 1). Figures 4,5, and 6 show ocular images obtained from a patient treated with intravitreal bevacizumab plus PDT as initial treatment. Table 1 Combined intravitreal anti-VEGF and photodynamic therapy for retinal angiomatous proliferation Three of the 13 eyes needed no additional treatment during 24 months.…”

Retinal Angiomatous Proliferation

“…14 A recent editorial by N. Bressler, reviewing retrospective data from the TAP and Verteporfin in Photodynamic Therapy trials, has suggested that the prognosis of untreated lesions with anastomosis is similar to that of lesions without anastomosis, and that the response to treatment of both may be similar to that of CNV. [15][16][17][18] However, this cohort of patients may not have had the same characteristics as those described by us or other authors because of the lack of ICGA. 1,3,5,6,10,11 Our findings confirm previous reports that RAP lesions may have different clinical and angiographic features from those of CNV in exudative AMD.…”

Long-Term Management of RAP Lesions in Clinical Practice: Treatment Efficacy and Predictors of Functional Improvement

“…RAP is believed to have a worse natural history than other subtypes of exudative AMD [23]. Over the past years, the success rate of the various available treatments has been inconsistent.…”

Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation

“…RAP is known to have poor visual outcomes compared with typical exudative AMD [4,5,9,13]. In addition, the risk of neovascularization in the fellow eye is higher for patients with RAP than for those with other forms of neovascular AMD [6].…”

“…At month 24, OCT revealed the recurrence of CME in three eyes, the recurrence of PED in one eye, and remaining PED in one eye (Table 1). Figures 4,5, and 6 show ocular images obtained from a patient treated with intravitreal bevacizumab plus PDT as initial treatment. Table 1 Combined intravitreal anti-VEGF and photodynamic therapy for retinal angiomatous proliferation Three of the 13 eyes needed no additional treatment during 24 months.…”

Retinal Angiomatous Proliferation

“…14 A recent editorial by N. Bressler, reviewing retrospective data from the TAP and Verteporfin in Photodynamic Therapy trials, has suggested that the prognosis of untreated lesions with anastomosis is similar to that of lesions without anastomosis, and that the response to treatment of both may be similar to that of CNV. [15][16][17][18] However, this cohort of patients may not have had the same characteristics as those described by us or other authors because of the lack of ICGA. 1,3,5,6,10,11 Our findings confirm previous reports that RAP lesions may have different clinical and angiographic features from those of CNV in exudative AMD.…”

Long-Term Management of RAP Lesions in Clinical Practice: Treatment Efficacy and Predictors of Functional Improvement

“…RAP is believed to have a worse natural history than other subtypes of exudative AMD [23]. Over the past years, the success rate of the various available treatments has been inconsistent.…”

Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation

“…RAP is known to have poor visual outcomes compared with typical exudative AMD [4,5,9,13]. In addition, the risk of neovascularization in the fellow eye is higher for patients with RAP than for those with other forms of neovascular AMD [6].…”

“…At month 24, OCT revealed the recurrence of CME in three eyes, the recurrence of PED in one eye, and remaining PED in one eye (Table 1). Figures 4,5, and 6 show ocular images obtained from a patient treated with intravitreal bevacizumab plus PDT as initial treatment. Table 1 Combined intravitreal anti-VEGF and photodynamic therapy for retinal angiomatous proliferation Three of the 13 eyes needed no additional treatment during 24 months.…”

Retinal Angiomatous Proliferation

“…14 A recent editorial by N. Bressler, reviewing retrospective data from the TAP and Verteporfin in Photodynamic Therapy trials, has suggested that the prognosis of untreated lesions with anastomosis is similar to that of lesions without anastomosis, and that the response to treatment of both may be similar to that of CNV. [15][16][17][18] However, this cohort of patients may not have had the same characteristics as those described by us or other authors because of the lack of ICGA. 1,3,5,6,10,11 Our findings confirm previous reports that RAP lesions may have different clinical and angiographic features from those of CNV in exudative AMD.…”